1ARKK

ARK Innovation 1X

ETFs & Funds · EUR · LSE

1ARKETFT212

Price

€3.529

+2.99%

Cap

Earnings

30d Trend

+7.4%

1ARKK
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

35% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level58
Momentum68
Technical55
Fund Quality53
Cost Efficiency31

Raw weighted: 49×Macro 0.99 (1%)=49

RISK

58/100
90d Volatility
35.1%High
ATR %
2.6%Normal
Max Drawdown (1Y)
-29.2%Normal

MOMENTUM

68/100
12-1M Momentum
+31.7%Strong uptrend
6-1M Momentum
-7.9%Negative
1M Return
+4.2%Stable

TECHNICAL

55/100
RSI (14)
56.9Neutral
Price vs SMA200
-0.4%Flat
MACD
-0.20Bearish momentum
Bollinger Band
76%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.096Noisy/choppy

FUND QUALITY

53/100
Replication
SyntheticUses swaps (counterparty risk)
Holdings
33 positionsConcentrated
Domicile
Ireland (tax-efficient)15% US withholding tax
Yield
0.00% (Accumulating)Growth-focused

COST EFFICIENCY

31/100
Expense Ratio
0.75%Moderate
Fund Size (AUM)
$8MMicro (closure risk)

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months47
3-12 months54
1-5+ years48

Medium-term outlook is neutral — no clear directional thesis

BRAIN47'S ASSESSMENT

I rate ARK Innovation 1X at 49/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 68/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+4.2%

3 MONTHS

+7.2%

12 MONTHS

+35.9%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Medium-term outlook is neutral — no clear directional thesis. Momentum (68) and Technical (55) are the primary strengths. I note that cost efficiency is the weakest area at 31/100 — this warrants monitoring. Historical volatility is moderate at 35%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 49/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.